SecBot SecBot
SC 13G ·Filed Nov 13, 2026

TCMD

TACTILE SYSTEMS TECHNOLOGY INC
NEUTRAL
Impact 4/10
Horizonweeks Processed3d 10h ago SEC0000895421-26-000322
Passive investor 5%+ stake
Actionable Insight • Neutral

Monitor for any future amendments that could signal a shift from passive to active intent, though the 13G certification makes that unlikely. The stake adds a major institutional holder, which may provide a floor for the stock, but the passive nature limits near-term catalyst potential.

DirectionNeutral
Confidencehigh
Horizonweeks

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Morgan Stanley disclosed a 7.2% passive stake in Tactile Systems Technology via a new Schedule 13G, representing 1,632,031 shares as of September 30, 2026. This is a new filer for TCMD, adding a large institutional holder to the register. The filing certifies passive intent and follows a Q3 earnings report that showed modest revenue growth but an EPS miss.

Key Financial Metrics

Stake
7.2%
Stake Value
$44.0M
Investor
Morgan Stanley

Key Facts

  • Morgan Stanley filed a new Schedule 13G disclosing beneficial ownership of 1,632,031 shares of Tactile Systems Technology (TCMD) common stock.
  • The stake represents 7.2% of shares outstanding as of September 30, 2026.
  • The filing certifies passive intent under Rule 13d-1(b), with no purpose of changing or influencing control.
  • This is Morgan Stanley's first SC 13G filing for TCMD; no prior stake was reported by this filer.
  • The filing date (November 13, 2026) is 11 days after TCMD's Q3 2026 earnings release on November 2, 2026.

Financial Impact

7.2% stake valued at approximately $44M based on $608M market cap

ownership concentration

Risk Factors

  • Morgan Stanley's stake may be part of broader index or quantitative strategies and could be reduced without notice.
  • The filing does not disclose cost basis or whether the position was built before or after the Q3 earnings miss.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
90% bullish (10 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G Filing (Primary)0000895421-26-000322
Document: 0000895421-26-000322-index.html0000895421-26-000322
Document: 0000895421-26-000322.txt0000895421-26-000322

Track record

17 reports on TCMD

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $26.99 Now $26.37 −2.30% settles Feb 12
  2. Nov 13, 20263d ago SC 13G Neutral 4/10 Viewing Entry $27.11 Now $26.37 −2.73% settles Feb 12
  3. Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $26.62 Now $26.37 −0.94% settles Feb 8
  4. Nov 6, 202610d ago 3 Neutral 2/10 Entry $26.59 Now $26.37 −0.83% settles Feb 5
  5. Nov 3, 202613d ago 144 Neutral 2/10 Entry $24.78 Now $26.37 +6.42% settles Feb 1
  6. Nov 2, 202614d ago 10-Q/A Neutral 2/10 Entry $24.78 Now $26.37 +6.42% settles Feb 1
  7. Nov 2, 202614d ago 10-Q/A Neutral 2/10 Entry $24.78 Now $26.37 +6.42% settles Feb 1
  8. Nov 2, 202614d ago Press Release Bearish 5/10 No price data
  9. Nov 2, 202614d ago 8-K Mixed 5/10 Entry $24.78 Now $26.37 +6.42% settles Feb 1
  10. Oct 19, 202628d ago Press Release Neutral 3/10 Entry $23.52 Now $26.37 +12.12% settles Jan 15
Showing 10 of 17

US Market Status

Market Closed · Opens in 6h 35m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 13, 2026